Quote:   Recent

Prometic Life Sciences Inc.

Exchange: TSX Exchange
Mar 22, 2019, 4:00 PM EDT
-0.01 (-1.61%)
Vol: 1,295,167
Real-time price

Company Profile

Description & Contact Information
Business Description: Prometic Life Sciences Inc is a global biopharmaceutical corporation supplying technologies for Bioseparations while also developing its own orphan drugs, plasma-derived therapeutics and small-molecule therapeutic products targeting unmet medical needs in the field of fibrosis, autoimmune disease/inflammation and cancer. The company also offers drug purification of biologics, drug development, proteomics and the elimination of pathogens. The company's segments consist of the Small molecule therapeutics segment, the Plasma-derived therapeutics segment and the Bioseparations segment. Majority of the revenue is derived from the Small molecule therapeutics segment that develops drug candidates for rare or orphan indications.
Address: 440, Boulevard Armand-Frappier, Suite 300, Laval, QC, CAN, H7V 4B4
Telephone: +1 450 781-0115
Facsimile: +1 450 781-4477
Website: http://www.prometic.com
Email: info@prometic.com
Fiscal Year End: 12/2017
Industry Classifications:
Sector: Healthcare
Industry: Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing(325412)
CIK: 1351172
SIC: 3741
Copyright © QuoteMedia, Inc. quotemedia.com
Data delayed 15 minutes unless otherwise indicated.

Terms of Service | Privacy Policy

© TSX Inc., a wholly owned subsidiary of TMX Group Inc.